These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3984 related articles for article (PubMed ID: 6867027)

  • 21. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
    Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer/testis genes expression in human melanoma cell lines.
    Mikhaylova IN; Kovalevsky DA; Morozova LF; Golubeva VA; Cheremushkin EA; Lukashina MI; Voronina ES; Burova OS; Utyashev IA; Kiselev SL; Demidov LV; Beabealashvilli RSh; Baryshnikov AY
    Melanoma Res; 2008 Oct; 18(5):303-13. PubMed ID: 18781128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of antigens 15.75 and p3.58 on primary melanoma and benign nevi.
    Holzmann B; Johnson JP; Kaudewitz P; Braun-Falco O; Riethmüller G
    Behring Inst Mitt; 1984 May; (74):24-6. PubMed ID: 6477355
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of cell-surface human melanoma-associated antigens identified by rabbit and murine antibodies.
    Bystryn JC; Jacobsen JS; Liu P; Heaney-Kieras J
    Hybridoma; 1982; 1(4):465-72. PubMed ID: 6208141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.
    Houghton AN; Eisinger M; Albino AP; Cairncross JG; Old LJ
    J Exp Med; 1982 Dec; 156(6):1755-66. PubMed ID: 7175440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of tumor-regression antigens in melanoma.
    Kawakami Y; Robbins PF; Wang RF; Rosenberg SA
    Important Adv Oncol; 1996; ():3-21. PubMed ID: 8791125
    [No Abstract]   [Full Text] [Related]  

  • 27. PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen.
    Rochaix P; Lacroix-Triki M; Lamant L; Pichereaux C; Valmary S; Puente E; Al Saati T; Monsarrat B; Susini C; Buscail L; Delsol G; Voigt JJ
    Mod Pathol; 2003 May; 16(5):481-90. PubMed ID: 12748255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of monoclonal antibody-defined antigens by human colorectal carcinoma and melanoma cells.
    Steplewski Z; Chang TH; Herlyn M; Koprowski H
    Cancer Res; 1981 Jul; 41(7):2723-7. PubMed ID: 7248940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibody-defined antigens on tumor cells.
    Baldwin RW; Embleton MJ; Price MR
    Biomembranes; 1983; 11():285-312. PubMed ID: 6338949
    [No Abstract]   [Full Text] [Related]  

  • 30. Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation.
    Houghton AN; Albino AP; Cordon-Cardo C; Davis LJ; Eisinger M
    J Exp Med; 1988 Jan; 167(1):197-212. PubMed ID: 2891780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells.
    Pietra G; Mortarini R; Parmiani G; Anichini A
    Cancer Res; 2001 Nov; 61(22):8218-26. PubMed ID: 11719453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of human tumor-specific antibodies by selection of an antibody phage library on melanoma cells.
    Kupsch JM; Tidman NH; Kang NV; Truman H; Hamilton S; Patel N; Newton Bishop JA; Leigh IM; Crowe JS
    Clin Cancer Res; 1999 Apr; 5(4):925-31. PubMed ID: 10213230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of surface antigens of transplantable melanoma in hamsters. I. Studies on serological reactivity of sera with isolated melanocytes by using the immunoadherence test.
    Kozłowska K; Kostulak A; Zurawska-Czupa B
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):59-66. PubMed ID: 6477065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunology of malignant melanoma].
    Bourgoin JJ
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):789-807. PubMed ID: 4559237
    [No Abstract]   [Full Text] [Related]  

  • 35. Differentiation status of rat ductal cells and ethionine-induced hepatic carcinomas defined with surface-reactive monoclonal antibodies.
    Hixson DC; Brown J; McBride AC; Affigne S
    Exp Mol Pathol; 2000 Jun; 68(3):152-69. PubMed ID: 10816384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytotoxic T-cell immune response against melanoma antigens].
    Ayyoub M
    Ann Dermatol Venereol; 1998 Nov; 125 Suppl 2():S34-6. PubMed ID: 9922891
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of monoclonal antibody 225.28S in the study of nevus cells in culture].
    Raffaelli M; Fimiani M; Castelli A; Mancianti ML; Valentino A; Andreassi L
    Boll Soc Ital Biol Sper; 1984 Mar; 60(3):467-71. PubMed ID: 6370274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological detection of altered signaling molecules involved in melanoma development.
    Kawakami Y; Sumimoto H; Fujita T; Matsuzaki Y
    Cancer Metastasis Rev; 2005 Jun; 24(2):357-66. PubMed ID: 15986143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanosomal antigenic expression on the cell surface and intracellular subunits within melanogenic compartments of pigment cells: analysis by antimelanosome-associated monoclonal antibody.
    Hayashibe K; Mishima Y; Ichihashi M; Kawai M
    J Invest Dermatol; 1986 Jul; 87(1):89-94. PubMed ID: 3522755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD109 expression levels in malignant melanoma.
    Ohshima Y; Yajima I; Kumasaka MY; Yanagishita T; Watanabe D; Takahashi M; Inoue Y; Ihn H; Matsumoto Y; Kato M
    J Dermatol Sci; 2010 Feb; 57(2):140-2. PubMed ID: 20034764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 200.